What’s comical is that all of the links you posted are from NIH (the largest biomedical research agency in the world.
Now, I’m about 99.9999999999% sure dipshit doesn’t know that stands for the National Institute of Heath, which is a department of DHHS (Department of Health and Human Services). The department that would likely be in charge of single-payer if it were to occur here.
They can’t be trusted on Stem Cells, but they’ll run all of healthcare.
Like I’ve said before, hopefully single-payer is only the beginning and that the private money is taken out of the political system. Another thing you can’t seem to comprehend.
Is that all you can do when you can’t refute someone is call names. No wonder you’re a republican. Reminds me of Cruz when he couldn’t defeat Sanders on the issue he resorted to republican boogeyman words like socialism. It was done in effort to illicit a knee-jerk reaction among easily duped followers.
He distrusts the government (FDA) process for testing and approving new therapies, but wants single-payer healthcare, where literally every single decision on the approval, implementation and cost of new therapies will have to come from the government (since the government will be paying for it).
You have a habit of merely copying and pasting the names of these links whenever challenged to provide evidence for these therapies, but it’s clear even from reading the titles of these articles that you have no idea what they mean or what they showed; you merely copy and pasted them from a list of studies. If you did actually read the studies, you would know that:
These are all lab-based, mouse studies. None of them demonstrates that a particular therapy can be successfully implemented, much less improve clinical outcomes, in humans. They are what we call “pre-clinical” research - part of the long slog necessary in understanding biologic processes at work and identifying potential therapeutic targets. They are important work; they do not provide evidence for the efficacy of cell therapy in humans, not even close.
The four PubMed links that I posted were a substantial summation of all human trials that have been performed to date (encompassing dozens of trials; several of the articles were meta-analyses that aggregated data from 30+ individual randomized trials). That’s quite a bit more power than copy/pasting the titles of a few mouse studies, which are useful as early-stage, proof-of-concept studies to help us understand the biologic process at work and how the new therapy might be delivered in humans. However, they need to be followed by human studies showing improvement in clinical outcomes. It doesn’t do a whole lot of good to prove that stem cells injected into the tail of a mouse can make it to the heart unless that is followed by a study showing that those stem cells making it to the heart actually improved heart function, reduced the need for medications and/or hospitalization, or reduced mortality.
I don’t have to, after activities guy and usmc have provided you with a mountain of evidence, I believe the burden is now on you, I know my role when in this, and I figure the more you’re here, bantering with me, the less you’re talking to people in the real world and pushing this swill. But no, I’m the ignoraymoose here, and gladly work in this capacity.
Early trials using autologous CSC in patient. Look what I found as I scanned over the information from the work done by The Stem Cell Institute in Panama.
the follow-up of our patients enrolled in the clinical studies.
METHODS: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) trial, a prospective, multicenter, randomized trial, was conducted in patients with heart failure of ischemic origin who received standard of care or standard of care plus lineage-specified stem cells.